The DOI matches its Crossref record; 16 of the 16 references it cites were found in a registry or an index.
Effect of Direct-to-Consumer Genomewide Profiling to Assess Disease Risk
Open accessAbstract
BACKGROUND: The use of direct-to-consumer genomewide profiling to assess disease risk is controversial, and little is known about the effect of this technology on consumers. We examined the psychological, behavioral, and clinical effects of risk scanning with the Navigenics Health Compass, a commercially available test of uncertain clinical validity and utility. METHODS: We recruited subjects from health and technology companies who elected to purchase the Health Compass at a discounted rate. Subjects reported any changes in symptoms of anxiety, intake of dietary fat, and exercise behavior at a mean (±SD) of 5.6±2.4 months after testing, as compared with baseline, along with any test-related distress and the use of health-screening tests. RESULTS: From a cohort of 3639 enrolled subjects, 2037 completed follow-up. Primary analyses showed no significant differences between baseline and follow-up in anxiety symptoms (P=0.80), dietary fat intake (P=0.89), or exercise behavior (P=0.61). Secondary analyses revealed that test-related distress was positively correlated with the average estimated lifetime risk among all the assessed conditions (β=0.117, P<0.001). However, 90.3% of subjects who completed follow-up had scores indicating no test-related distress. There was no significant increase in the rate of use of screening tests associated with genomewide profiling, most of which are not considered appropriate for screening asymptomatic persons in any case. CONCLUSIONS: In a selected sample of subjects who completed follow-up after undergoing consumer genomewide testing, such testing did not result in any measurable short-term changes in psychological health, diet or exercise behavior, or use of screening tests. Potential effects of this type of genetic testing on the population at large are not known. (Funded by the National Institutes of Health and Scripps Health.).
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
(1970) · Cited by 24,983
Jacobson, N. S., & Truax, P. (1991) · Journal of Consulting and Clinical Psychology · doi:10.1037/0022-006x.59.1.12 · Cited by 7,770
A simple method to assess exercise behavior in the community.
Godin, G., & Shephard, R. J. (1985) · PubMed · Cited by 3,824
The Impact of Event Scale: Revised
Weiss, D. S. (2007) · International and Cultural Psychology Series · doi:10.1007/978-0-387-70990-1_10 · Cited by 2,996
Psychometric properties of the Impact of Event Scale—Revised
Creamer, M., Bell, R., & Failla, S. (2003) · Behaviour Research and Therapy · doi:10.1016/j.brat.2003.07.010 · Cited by 1,947
A simultaneous evaluation of 10 commonly used physical activity questionnaires
JACOBS, D. R., AINSWORTH, B. E., HARTMAN, T. J., & LEON, A. S. (1993) · Medicine & Science in Sports & Exercise · doi:10.1249/00005768-199301000-00012 · Cited by 1,675
A rapid food screener to assess fat and fruit and vegetable intake
Block, G., Gillespie, C., Rosenbaum, E. H., & Jenson, C. (2000) · American Journal of Preventive Medicine · doi:10.1016/s0749-3797(00)00119-7 · Cited by 565
Disclosure of APOE Genotype for Risk of Alzheimer's Disease
Green, R. C., Roberts, J. S., Cupples, L. A., Relkin, N. R., Whitehouse, P. J., Brown, T., Eckert, S. L., Butson, M., Sadovnick, A. D., Quaid, K. A., et al. (2009) · New England Journal of Medicine · doi:10.1056/nejmoa0809578 · Cited by 554
An agenda for personalized medicine
Ng, P. C., Murray, S. S., Levy, S., & Venter, J. C. (2009) · Nature · doi:10.1038/461724a · Cited by 330
A systematic review of perceived risks, psychological and behavioral impacts of genetic testing
Heshka, J. T., Palleschi, C., Howley, H., Wilson, B., & Wells, P. S. (2008) · Genetics in Medicine · doi:10.1097/gim.0b013e31815f524f · Cited by 328
Cited by
The personal and clinical utility of polygenic risk scores
Torkamani, A., Wineinger, N. E., & Topol, E. J. (2018) · Nature Reviews Genetics · doi:10.1038/s41576-018-0018-x · Cited by 1,623
Self-citationKilpeläinen, T. O., Qi, L., Brage, S., Sharp, S. J., Sonestedt, E., Demerath, E., Ahmad, T., Mora, S., Kaakinen, M., Sandholt, C. H., et al. (2011) · PLoS Medicine · doi:10.1371/journal.pmed.1001116 · Cited by 559
Genetics of breast cancer: a topic in evolution
Shiovitz, S., & Korde, L. A. (2015) · Annals of Oncology · doi:10.1093/annonc/mdv022 · Cited by 525
Point-of-Care Diagnostics: Recent Developments in a Connected Age
Nayak, S., Blumenfeld, N. R., Laksanasopin, T., & Sia, S. K. (2017) · Analytical Chemistry · doi:10.1021/acs.analchem.6b04630 · Cited by 508
Berg, J. S., Khoury, M. J., & Evans, J. P. (2011) · Genetics in Medicine · doi:10.1097/gim.0b013e318220aaba · Cited by 490
Hollands, G. J., French, D. P., Griffin, S. J., Prevost, A. T., Sutton, S., King, S., & Marteau, T. M. (2016) · BMJ · doi:10.1136/bmj.i1102 · Cited by 483
Goodarzi, M. O. (2018) · The Lancet Diabetes & Endocrinology · doi:10.1016/s2213-8587(17)30200-0 · Cited by 470
Celis-Morales, C., Livingstone, K. M., Marsaux, C. F. M., Macready, A. L., Fallaize, R., O’Donovan, C. B., Woolhead, C., Forster, H., Walsh, M. C., Navas-Carretero, S., et al. (2016) · International Journal of Epidemiology · doi:10.1093/ije/dyw186 · Cited by 399
“reported 44% and 63% dropouts at months 3 and 12, respectively.(22,27) Moreover, the profile of those interested in participating in the Food4Me intervention study was similar to that of European adults,(11,17) most of whom would benefit from improved diet and more physical activity.”
Maas, P., Barrdahl, M., Joshi, A. D., Auer, P. L., Gaudet, M. M., Milne, R. L., Schumacher, F. R., Anderson, W. F., Check, D., Chattopadhyay, S., et al. (2016) · JAMA Oncology · doi:10.1001/jamaoncol.2016.1025 · Cited by 373
Kullo, I. J., Jouni, H., Austin, E. E., Brown, S.-A., Kruisselbrink, T. M., Isseh, I. N., Haddad, R. A., Marroush, T. S., Shameer, K., Olson, J. E., et al. (2016) · Circulation · doi:10.1161/circulationaha.115.020109 · Cited by 267
Public Knowledge of and Attitudes Toward Genetics and Genetic Testing
Haga, S. B., Barry, W. T., Mills, R., Ginsburg, G. S., Svetkey, L., Sullivan, J., & Willard, H. F. (2013) · Genetic Testing and Molecular Biomarkers · doi:10.1089/gtmb.2012.0350 · Cited by 266
Cardiovascular disease: The rise of the genetic risk score
Knowles, J. W., & Ashley, E. A. (2018) · PLOS Medicine · doi:10.1371/journal.pmed.1002546 · Cited by 182
Disclosure of genetic information and change in dietary intake: a randomized controlled trial
Nielsen, D. E., & El-Sohemy, A. (2014) · PLoS ONE · doi:10.1371/journal.pone.0112665 · Cited by 157
Direct-to-consumer genetic testing
Horton, R., Crawford, G., Freeman, L., Fenwick, A., Wright, C. F., & Lucassen, A. (2019) · BMJ · doi:10.1136/bmj.l5688 · Cited by 151
Learning one’s genetic risk changes physiology independent of actual genetic risk
Turnwald, B. P., Goyer, J. P., Boles, D. Z., Silder, A., Delp, S. L., & Crum, A. J. (2018) · Nature Human Behaviour · doi:10.1038/s41562-018-0483-4 · Cited by 142
Personalising nutritional guidance for more effective behaviour change
Celis-Morales, C., Lara, J., & Mathers, J. C. (2015) · Proceedings of the Nutrition Society · doi:10.1017/s0029665114001633 · Cited by 130
Bonter, K., Desjardins, C., Currier, N., Pun, J., & Ashbury, F. D. (2011) · BMJ Open · doi:10.1136/bmjopen-2011-000110 · Cited by 111
Implementation and utilization of genetic testing in personalized medicine
Scott, S., Abul-Husn, N., Owusu Obeng, A., Sanderson, S., & Gottesman, O. (2014) · Pharmacogenomics and Personalized Medicine · doi:10.2147/pgpm.s48887 · Cited by 106
Direct-to-consumer genomics on the scales of autonomy
Vayena, E. (2015) · Journal of Medical Ethics · doi:10.1136/medethics-2014-102026 · Cited by 62
Puryear, L., Downs, N., Nevedal, A., Lewis, E. T., Ormond, K. E., Bregendahl, M., Suarez, C. J., David, S. P., Charlap, S., Chu, I., et al. (2018) · Journal of Community Genetics · doi:10.1007/s12687-017-0349-x · Cited by 31
Personalized Medicine Through SNP Testing for Breast Cancer Risk: Clinical Implementation
Howe, R., Miron‐Shatz, T., Hanoch, Y., Omer, Z. B., O'Donoghue, C., & Ozanne, E. M. (2015) · Journal of Genetic Counseling · doi:10.1007/s10897-014-9803-7 · Cited by 26
Metadata
- Authors
- Bloss, C. S., Schork, N. J., & Topol, E. J.
- Venue
- New England Journal of Medicine
- Publisher
- Massachusetts Medical Society
- Published
- 2011-02-10
- Volume
- 364
- Issue
- 6
- Pages
- 524-534
- ISSN
- 0028-4793 (ISSN-L)
- 1533-4406
- OpenAlex
- W2153483268
- Cited by
- 562
- References
- 16
- FWCI
- 47.87
- Type
- journal article
- Language
- en
- Open access
- bronze
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.